Teladoc (TDOC) closed slightly higher, but underperformed sector and market

From Nasdaq: 2024-07-12 18:15:19

Teladoc (TDOC) closed at $9.39, a +0.21% change from the previous day. S&P 500 rose 0.55%, Dow up 0.62%, and Nasdaq gained 0.63%. In the past month, TDOC shares fell 5.83%, underperforming Medical sector (0.19%) and S&P 500 (4.28%).

Teladoc’s upcoming earnings project -$0.35 EPS with 12.5% growth, revenue at $649.56 million, down 0.44% YoY. Full-year estimates show -$1.05 EPS and $2.65 billion revenue, with +21.64% and +1.8% changes over last year. Analysts’ revisions are crucial indicators of near-term trends and stock performance.

Zacks Rank system indicates TDOC as a #3 (Hold), with historical outperformance of +25% annual return since 1988. Industry rank for Medical Services industry is 102 within the top 41% of 250 industries, with top-ranked sectors outperforming the bottom half by 2 to 1. Stay updated on Zacks.com for TDOC news.

Analysts suggest looking at “Whisper” stocks for potential surprises. Stocks could jump +10-20% upon earnings release. For latest stock recommendations and reports from Zacks Investment Research, download the 7 Best Stocks for the Next 30 Days. Analysts might be underestimating these stocks, potentially leading to positive surprises.



Read more at Nasdaq: Teladoc (TDOC) Ascends But Remains Behind Market: Some Facts to Note